about
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists[Perspective of use of agonists of adenosine and opioid receptors for prevention of reperfusion damages of heart. Analysis of experimental and clinical data].Prospects of Using of κ-Opioid Receptor Agonists U-50,488 and ICI 199,441 for Improving Heart Resistance to Ischemia/Reperfusion.Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction.Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists.Chronic intermittent hypobaric hypoxia antagonizes renal vascular hypertension by enhancement of vasorelaxation via activating BKCa.Specific features of adaptation of rats to chronic cold treatment.Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels.Role of Intracellular Calcium and Cyclic Nucleotides in Realization of Cardioprotective Effects of δ(1)- and κ(1)-Opioid Receptor Agonists.Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion.Receptor specificity of the antiarrhythmic effect produced by opioid peptides Dalargin and DADLE during myocardial reperfusion.Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism.[Adaptive phenomenon of ischemic postconditioning of the heart. Perspectives of clinical use].Effect of in vivo and in vitro stimulation of delta1-opioid receptors on myocardial resistance to arrhythmogenic action of ischemia and reperfusion.Contribution of Opioid Receptors to the Cytoprotective Effect of the Adaptation to Chronic Hypoxia at Anoxia/Reoxygenation of Isolated Cardiomyocytes.Negative inotropic and chronotropic effects of delta-opioid receptor antagonists are mediated via non-opioid receptors.Effects of μ-Opioid Receptor Agonist DAMGO on Heart Contractility and Necrotic Injury to Cardiomyocytes during Ischemia and Reperfusion of Isolated Rat Heart.Cardioprotective effect of kappa1-opioid receptor activation and role of cAMP in its realization.Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists.Activation of peripheral delta opioid receptors increases cardiac tolerance to arrhythmogenic effect of ischemia/reperfusion.The Role of Endogenous Opioid System in the Regulation of Heart Tolerance to Stress-Induced Damage.Participation of central kappa-opioid receptor in arrhythmogenesis.Preserved cardiac mitochondrial function and reduced ischaemia/reperfusion injury afforded by chronic continuous hypoxia: role of opioid receptors.Participation of central and peripheral kappa 1 and kappa 2 opioid receptors in arrhythmogenesis.Effect of opiate peptide dalargin and des-Tyr-dalargin on cardiac pump function during ischemia-reperfusion.Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway.Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusion.Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart.Prospects for the Use of Cannabinoid Receptor Ligands for the Treatment of Metabolic Syndrome and Atherosclerosis: Analysis of Experimental and Clinical Data.Role of ATP-Sensitive K+ Channels in Myocardial Infarct Size-Limiting Effect of Chronic Continuous Normobaric Hypoxia.The Role of Reactive Oxygen Species in the Pathogenesis of Adipocyte Dysfunction in Metabolic Syndrome. Prospects of Pharmacological Correction.Negative chronotropic effect of cannabinoids and their water-soluble emulsion is related to activation of cardiac CB1 receptors.Myocardial Protection against Ischemic and Reperfusion Injuries (Experimental Study).Effects of Deltorphin II and Its Retroenantio Analog on Cardiac Tolerance to Ischemia and Reperfusion.CB-Receptor Agonist HU-210 Mimics the Postconditioning Phenomenon of Isolated Heart.Endomorphins and β-Endorphin Do Not Affect Heart Tolerance to the Pathogenic Effect of Reperfusion.Involvement of Protein Kinase C-δ in the Realization of Cardioprotective Effect of Ischemic Postconditioning.Effect of Hypoxic Preconditioning on Stress Reaction in Rats.Role of β-Adrenoceptors and L-Type Ca(2+)-Channels in the Mechanism of Reperfusion-Induced Heart Injury.Functional state of myocardial mitochondria in ischemia reperfusion of the heart in rats adapted to hypoxia.
P50
Q28066192-9EE83ED4-4174-427C-9675-37D62BB8101BQ30882761-BB4BCBD8-6770-4331-8FD4-B8DA7D6F71F6Q34500012-E736DD42-D5AA-4FCE-BC82-F1F377C39B18Q34684375-42DB5FB8-B256-4B36-9630-2F7B2E391506Q38612812-E66F2116-95BE-4FAB-96FD-CA16525FFE41Q38842479-553833F1-99F0-462C-B53F-666DA18671A1Q39206157-16908F28-0F29-43AF-8403-ECCFFFA33AD9Q42776807-88367313-F47B-483B-92EC-55350AFD7BF2Q42790244-7AE41D7E-4D9F-4F88-B7C9-CB1BF8A73AC1Q43756262-5B1E88CE-715E-4CE5-9C1F-DBF4C7EE276EQ44068815-D4D4FC20-C189-4D8A-88F5-CA5A09D5C096Q44213873-9A46FB02-6C96-44DB-8DB2-367BAE984955Q44267001-6B6C1D0D-DAF7-4C0C-943E-EA9C522097C5Q44282006-750DB8DD-D229-4CE7-A80B-76EC87C3ED0DQ44330239-F9823412-6BC2-4220-9F66-F36EE642499FQ44333101-F58A5E00-C812-4748-8BA5-7FCE0E36A732Q44333213-1EDAC550-ECD6-458D-ADB5-3206A493406AQ44336900-67E635DE-126E-4630-8AEE-ED698F224878Q44341093-EC672C6B-92B9-4DC9-AEFB-2D2E00BA1932Q44343475-C1A25509-A858-48D2-A6B8-ED4551603A06Q44346224-AC689EA8-AAEC-45DB-BE5D-1C7B538E11E7Q44346293-DFDE3C16-82DE-453C-A15D-E1851DC5B0F2Q44349980-438E4C9C-0E07-4F49-B783-26D8AFB8C096Q44352834-774E595D-7BA6-4E6C-82C4-11A58700FD1DQ44845325-66311DB4-F110-4E0C-A496-B0E629E92597Q46088661-CF926918-A58E-459E-8B44-C3E1A1D12567Q46162246-A8642F09-451E-420B-B02B-1CF29104E861Q46752509-7B83A5D9-CCC6-4896-A934-3DF27B6D597EQ47199039-0CAE999D-8A26-498F-B76D-65420A16E7EFQ47208633-D0346D19-4C56-444C-A04C-43285DDC7A6CQ48519582-537ACAA6-1D85-4442-8E36-0DEF7D66FFF0Q48607857-38BE7BB5-0B30-472C-A8A8-C7A08A91FDBEQ50100762-BF71F21B-5C4A-4C88-8B28-A646EBADC525Q51188740-150001F2-B8B8-4D6A-9149-562FB87A51B6Q51308648-58E135D3-2729-498F-9BDD-8FA2F2E7677EQ51308659-4B097450-6533-4395-8D38-F36E1D5B04CEQ51591600-4D27C2F1-6621-42DF-B505-0C66D7E9CC34Q51593809-6E3DCA8A-2498-41CB-AD45-38B964870FA5Q51716195-86069B0E-CAF6-45C6-AC22-B641BB0C4960Q51727475-B3C63D07-946D-4E96-83E0-9CCFB464BE25
P50
description
researcher
@en
wetenschapper
@nl
name
L N Maslov
@nl
Leonid Maslov
@en
Leonid Nikolajewitsch Maslow
@de
Леонид Николаевич Маслов
@ru
type
label
L N Maslov
@nl
Leonid Maslov
@en
Leonid Nikolajewitsch Maslow
@de
Леонид Николаевич Маслов
@ru
altLabel
L N Maslov
@en
Leonid Maslow
@de
Leonid Nikolayevich Maslov
@en
prefLabel
L N Maslov
@nl
Leonid Maslov
@en
Leonid Nikolajewitsch Maslow
@de
Леонид Николаевич Маслов
@ru
P106
P21
P31
P496
0000-0002-6020-1598